Buy Sermorelin for Sale
Sermorelin is a synthetic growth hormone secretagogue. Initially developed as a diagnostic tool for GH deficiency, Sermorelin has been shown to promote the secretions of human growth hormone and insulin-like growth factor 1 in clinical studies.
Clinical studies have further shown that Sermorelin increases lean body mass, sexual drive, and gonadotropin levels in adults. This synthetic peptide has also been shown to stimulate height increase in children with growth hormone deficiency.
What is Sermorelin?
Sermorelin is an analogue of the growth hormone releasing hormone (GHRH). Derived from the first 29 amino acids of the GHRH protein, this synthetic peptide has been reported to increase the production and release of growth hormone (GH) from the pituitary gland.
Sermorelin was initially developed as a potential diagnostic tool for GH deficiency (GHD). In 1997, the U.S. Food and Drug Administration (FDA) approved Sermorelin for the same. This synthetic peptide is also clinically used as a treatment option for adults with GHD. [R]
Clinical studies have shown that the potential effects of Sermorelin aren’t limited to stimulating GH secretion. It has also been found to increase height in GH-deficient children as well as increase sexual drive (libido) and lean body mass in age-advanced men. [R][R]
In preclinical studies, this synthetic growth hormone secretagogue has been shown to increase testosterone levels. A 2016 study involving pigs demonstrated that Sermorelin boosted heart health and reduced inflammatory responses following a heart attack. [R][R]
What is Sermorelin?
Sermorelin works by stimulating GHRH release via the hypothalamic-pituitary-somatotropic (HPS) axis. The HPS axis regulates the growth, development, and upkeep of the human body. One of its functions involves producing GHRH, which stimulates the pituitary gland to release GH. [R]
Sermorelin’s working mechanism distinguishes it from other growth hormone secretagogues. Most of which stimulate GH release via the ghrelin pathway. However, in both cases, the end goal is the same: stimulating the pituitary to release more GH into the bloodstream.
Over the years, numerous clinical and preclinical studies have been conducted to investigate the potential effects of Semaglutide. These studies have primarily examined the impact of this synthetic peptide on GH secretion, IGF-1 levels, height, lean body mass, and libido.
Here are the key findings from those studies:
1. Sermorelin and GH Deficiency
Multiple studies have shown that Sermorelin could potentially treat growth hormone deficiency.
In a 1996 study, once-daily Sermorelin therapy was reported to accelerate growth in children with GHD. One hundred and ten GH-deficient children were treated for up to 1 year. The group’s mean height velocity increased by 7.2 +/- 1.3 cm after 12 months of therapy. [R]
Another study involving 18 pre-pubertal children with GHD conveyed similar results. It reported that mean height velocity increased from 3.4 cm/year after 12 months of therapy. The children who were growing slowly before treatment had a greater growth than those growing normally. [R]
2. Sermorelin and IGF-1
Clinical studies have reported conflicting effects of Sermorelin on IGF-1.
For example, a study involving 9 young men and 10 elderly men linked twice-daily Sermorelin injections to increased IGF-1 levels. The study further reported that the elderly men continued to experience raised IGF-1 levels 2 weeks after the treatment was discontinued. [R]
However, in another study, once-nightly injections of Sermorelin failed to significantly increase IGF-1 levels in healthy elderly men. Both these studies raise the possibility that it’s the timing and frequency of Sermorelin treatment that determines its impact on IGF-1 levels. [R]
3. Sermorelin and Height
Sermorelin may induce growth-spurts in GH-deficient children.
A study published in March 1996 reported that once-daily Sermorelin injection was effective in increasing height velocity in GH-deficient children. The study found no adverse changes in general biochemical or hormonal analyses of the 86 enrolled children. [R]
Another study investigated the effects of Sermorelin therapy in 18 short pre-pubertal children. All of them were males were idiopathic short stature. Results from the study reveal that mean height velocity (average rate of growth) increased by 3.4 cm/year after 12 months of therapy. [R]
4. Sermorelin and Lean Body Mass
One solitary study has linked Sermorelin treatment to increased lean body mass in men.
Nineteen participants from both genders participated in the study and were given nightly Sermorelin injections for 4 months. Final results revealed that the male participants experienced a 1 kg increase in lean body mass after 120 days of treatment. [R]
The only adverse side-effect was transient hyperlipidemia (elevated levels of lipids). However, it resolved on its own by the end of the study.
5. Sermorelin and Sexual Drive
In the above trial, participants from both genders were asked to rate general well-being and libido after Sermorelin treatment. Men, not women, reported a significant increase in feelings of contentment and sexual drive following the therapy. [R]
Data from the study show that the improved libido was unrelated to changes in serum androgens. That is, serum testosterone, dihydrotestosterone (DHT) and sex-hormone binding globulin (SHBG) weren’t altered by Sermorelin treatment. [R]
6. Sermorelin and Muscle Strength
One clinical study has reported that Sermorelin could increase muscle strength and endurance. [R]
The study involved 11 healthy non-obese men aged 64 to 76 years. All were treated at home by nightly subcutaneous injections of 2 mg GHRH for 6 weeks.
At the end of the study, the participants experienced improvements in two muscles of muscle strength (upright row and shoulder press) and a test of muscle endurance.
7. Sermorelin and Heart Health
Animal studies have shown that Sermorelin may boost heart health.
A 2006 study evaluated the effects of Sermorelin treatment on pigs who had just suffered a heart attack. It found that this synthetic peptide reduced cardiac remodeling that generally follows a heart attack. Sermorelin was also linked to increased growth of blood cells in the damaged tissue. [R]
8. Sermorelin and Testosterone
Sermorelin may directly or indirectly raise testosterone levels.
In short children with pulsatile GH secretion, Sermorelin treatment stimulated the release of follicle-stimulating hormone (FSH) and (LH), implying a potential stimulation of testosterone production. [R]
Consistent with the above study, an investigation involving GH-deficient rats reported an increase in testosterone secretion following Sermorelin therapy. Both these studies imply a potential yet unproven role of Sermorelin in the treatment of hypogonadism. [R]
Is Sermorelin a steroid?
Sermorelin is an analogue of the growth hormone releasing hormone (GHRH). It induces the production of GHRH which, in turn, stimulates the pituitary gland to release more GH into the bloodstream.
What does Sermorelin do for your body?
Clinical studies have shown that Sermorelin increases GH production and IGF-1 levels in the body. This synthetic peptide has also been found to increase lean muscle mass, muscle endurance, and muscle strength in human studies.
What is the half-life of Sermorelin?
Sermorelin has a relatively short half-life of 11-12 minutes.
Does Sermorelin boost testosterone?
Preclinical studies have shown that Sermorelin therapy may raise testosterone levels.
Where to Buy Sermorelin for Sale?
Research Chems is the best place to buy Sermorelin for sale.
We have been around since 2023, supplying the highest-quality research compounds money can buy. Our products come with a 100% satisfaction guarantee, fast shipping, and great customer service to turn every customer into a repeat customer.
Sermorelin is an analogue of the growth hormone-releasing hormone (GHRH). It is clinically used to assess growth hormone secretion in children, though it can also stimulate the pituitary gland to secrete growth hormone and release it into the bloodstream.
Compared to other sources to increase growth hormone, Sermorelin is preferred. That is because it is regulated by physiological feedback mechanisms in the body. This enables it to sidestep problems associated with GH administration.
Clinical studies have shown that Sermorelin increases GH production and IGF-1 levels in adults and children with growth hormone deficiency. In preclinical studies, it has been shown to enhance bone density and testosterone production.
Research Chems sells Semaglutide (GLP-1) for laboratory and research use only.